However, limited information is available as to whether differences in PD-L1 expression profiles in SCRC and UC-associated dysplasia/colitic cancer are associated with the tumour-infiltrating immune cells/DSB/IRF-1 signalling axis in clinical samples from rare UC patients with UC-associated dysplasia/colitic cancer. This evidence concerns the gene CD274 and cancer.